Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for CELZ-201 in adults with recent-onset Type 1 diabetes across Phase 1 and Phase 2, currently recruiting to assess safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CELZ-201

Snippet

Sponsor: Creative Medical Technology Holdings Inc | Conditions: Type 1 Diabetes, Diabetes Mellitus, Type 1 | Phase 1, Phase 2 | Status: RECRUITING